Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences
Oliver S. Burren(AstraZeneca (United Kingdom)), Margarida Lopes(AstraZeneca (United Kingdom)), Neetu Razdan(AstraZeneca (United States)), Ian Henry(AstraZeneca (Sweden)), Yupu Liang(AstraZeneca (United Kingdom)), Zammy Fairhurst-Hunter(Centre for Human Genetics), Fengyuan Hu(Babraham Institute), Mohammad Bohlooly‐Y(AstraZeneca (Sweden)), Mark Lal(AstraZeneca (United Kingdom)), Regina Fritsche Danielson(AstraZeneca (United States)), Pernille Hansen(AstraZeneca (United Kingdom)), Abhishek Nag(King's College London), Katherine R. Smith(Murdoch Children's Research Institute), Carolina Haefliger(AstraZeneca (United Kingdom)), Douglas P. Loesch(University of Maryland, Baltimore), Kousik Kundu(University of Cambridge), Andrew R. Harper(AstraZeneca (United Kingdom)), Santosh S. Atanur(AstraZeneca (United Kingdom)), Ryan S. Dhindsa(Baylor College of Medicine), Sophia Cameron‐Christie(AstraZeneca (United Kingdom)), Henric Olsson(AstraZeneca (Sweden)), Benjamin Georgi(AstraZeneca (United Kingdom)), Jonathan Mitchell(AstraZeneca (United Kingdom)), Rasmus Ågren(AstraZeneca (United Kingdom)), Lisa Buvall(AstraZeneca (United Kingdom)), Dimitrios Vitsios(AstraZeneca (United Kingdom)), Lauren Anderson-Dring(AstraZeneca (United Kingdom)), Sonja Hess(Western Human Nutrition Research Center), Guillermo del Angel(Alexion Pharmaceuticals (United States)), Glenda Lassi(AstraZeneca (United Kingdom)), Adam Platt(AstraZeneca (United Kingdom)), Jennifer Harrow(AstraZeneca (Singapore)), Ben Hollis(AstraZeneca (United Kingdom)), Richard N. Hanna(AstraZeneca (United Kingdom)), Brian Dougherty(AstraZeneca (United States)), Manik Garg(AstraZeneca (United Kingdom)), Qiang Wu(East Carolina University), Wei Ding(Ministry of Education of the People's Republic of China), Xiao Jiang(Shandong Provincial Hospital), Sean Wen(Wellcome/MRC Cambridge Stem Cell Institute), David H. Baker(AstraZeneca (Sweden)), Shikta Das(University of Oxford), E. Suzanne Cohen(AstraZeneca (Switzerland)), Andrew Davis(AstraZeneca (Sweden)), Sri V. V. Deevi(University of Cambridge), Carmen Guerrero Rangel(AstraZeneca (United Kingdom)), Maria G. Belvisi(Lung Institute), Mårten Hammar(AstraZeneca (United Kingdom)), Zhongwu Lai(AstraZeneca (United States))
Cited by 54